Patent: 10,519,479
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 10,519,479
Title: | Methods for modifying glycosylation using manganese |
Abstract: | The present invention relates to a cell culture method for adjusting the proportion of G0, G1, G2, and high-mannose galactosylation variants in a population of a recombinant protein produced by a culture of cells in a cell culture medium by supplementing the cell culture medium with manganese at one or more days of the cell culture method duration. |
Inventor(s): | Solacroup; Thomas (Blonay, CH), Stettler; Matthieu (Vucherens, CH), Jordan; Martin (Ecublens, CH), Broly; Herve (Chatel-St Denis, CH) |
Assignee: | ARES TRADING S.A. (Aubonne, CH) |
Application Number: | 15/457,624 |
Patent Claims: | see list of patent claims |
Details for Patent 10,519,479
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2040-01-24 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | ⤷ Try a Trial | 2040-01-24 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 05/27/1999 | ⤷ Try a Trial | 2040-01-24 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 09/27/2004 | ⤷ Try a Trial | 2040-01-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |